Table 25-5.
Emphysema | Chronic Bronchitis | COPD | Asthma | RESTRICTION |
|||||
---|---|---|---|---|---|---|---|---|---|
Test | Parenchymal | Chest Wall | Neuromuscular | PVO | CHF | ||||
FVC (L) | (N)⇒ ↓ | (N)⇒ ↓ | (N)⇒ ↓ | (N)⇒ ↓ | ↓ | ↓ | N⇒ ↓ | N | ↓ |
FEV1 (L) | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | N⇒ ↓ | N | ↓ |
FEV1/FVC (%) | ↓ | ↓ | ↓ | N⇒ ↓ | N⇒↑ | N | N | N | N⇒ ↓ |
FEF (L/sec) | ↓ | ↓ | ↓ | ↓ | N⇒ ↓ | ↓ | N⇒ ↓ | N | ↓ |
PEF (L/sec) | ↓ | ↓ | ↓ | ↓ | N⇒ ↓ | ↓ | N⇒ ↓ | N | ↓ |
MVV (L/min) | ↓ | ↓ | ↓ | ↓ | N⇒ ↓ | ↓ | N⇒ ↓ | N | ↓ |
FEF50 (L/sec) | ↓ | ↓ | ↓ | ↓ | N⇒ ↓ | ↓ | N⇒ ↓ | N | ↓ |
TLC (L) | ↑ | N⇒↑ | ↑ | N⇒↑ | ↓ | ↓ | N⇒ ↓ | N⇒↓* | ↓ |
RV (L) | ↑ | ↑ | ↑ | ↑ | ↓ | ↓ | N⇒↑ | N | ↑⇒N⇒ ↓ |
RV/TLC (%) | ↑ | ↑ | ↑ | ↑ | N | N⇒↑ | N⇒↑ | N | ↑⇒N⇒ ↓ |
DlCO (mL/min/mm Hg) | ↓ | N⇒↓ | N⇒↓ | ↑⇒N | ↓ | N⇒↓ | N⇒↓ | ↓⇒N⇒↑ | ↓ |
Pao2 (mm Hg) | N⇒↓ | ↓ | N⇒↓ | N⇒↓ | ↓ | N | N⇒↓ | N⇒↓ | N⇒↓ |
Sao2 (%) | N⇒↓ | ↓ | N⇒↓ | N⇒↓ | ↓ | N | N⇒↓ | N⇒↓ | N⇒↓ |
Paco2 (mm Hg) | N⇒↑ | ↑ | N⇒↑ | N⇒↓ | N⇒↓ | N | N⇒↑ | ↓ | N⇒↓ |
pH (−log[H+]) | N⇒↓ | N⇒↓ | N⇒↓ | N⇒↑ | N⇒↑ | N | N⇒↓ | N | N⇒↑ |
Raw (cm H2O/L/sec) | ↑ | ↑ | ↑ | ↑ | ↓⇒N⇒↑ | N⇒↑ | N⇒↑ | N | N⇒↑ |
CstL (L/cm H2O) | ↑ | N | N⇒↑ | N⇒↑ | ↓ | N | N | N | N⇒↓ |
CdynL (L/cm H2O) | ↓ | N⇒↓ | N⇒↓ | N⇒↓ | ↓ | N | N | N | N ⇒↓ |
Pstmax (cm H2O) | ↓ | N | N⇒↓ | ↓ | N⇒↑ | N⇒↓ | N⇒↓ | N | N⇒↓ |
Phase III (% N2/L) | ↑ | ↑ | ↑ | ↑ | N⇒↑ | N | N | N | N⇒↑ |
Phase IV (% VC) | A | ↑⇒A | ↑⇒A | ↑⇒A | N⇒↑ | N | N | N | N⇒↑ |
MEP (cm H2O) | N⇒↓ | ↑ | ↓⇒N⇒↑ | N | N⇒↓ | N⇒↓ | ↓↓ | N | N |
MIP (cm H2O) | ↓ | N | N⇒↓ | N | N⇒↑ | N⇒↑ | ↓↓ | N | N |
A, often absent; N, normal; (N), occasionally normal; ⇒, to; ↑, increased; ↓, decreased. CdynL, dynamic compliance of the lung; CHF, congestive heart failure; CstL, static compliance of the lung; DlCO, diffusing capacity of the lung for carbon monoxide; Dl/Va, diffusing capacity of the lung/alveolar volume; FEF, forced expiratory flow; FEF50, forced expiratory flow after 50% of vital capacity exhaled; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; MEP, maximal expiratory pressure; MIP, maximal inspiratory pressure; MVV, maximal voluntary ventilation; Paco2, arterial Pco2; Pao2, arterial Po2; PEF, peak expiratory flow; Pstmax, maximal static pressure; PVO, pulmonary vascular obstruction; Raw, airway resistance; RV, residual volume; Sao2, arterial oxygen saturation; TLC, total lung capacity.
Volumes are decreased in the presence of primary pulmonary hypertension but not chronic thromboemboli.